dalteparin has been researched along with Acute Hemolytic Transfusion Reaction in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellido, M | 1 |
| van der Velden, VH | 1 |
| Leebeek, FW | 1 |
| te Boekhorst, PA | 1 |
| de Maistre, E | 1 |
| Terriat, B | 1 |
| Lesne-Padieu, AS | 1 |
| Abello, N | 1 |
| Bouchot, O | 1 |
| Steinmetz, EF | 1 |
2 other studies available for dalteparin and Acute Hemolytic Transfusion Reaction
| Article | Year |
|---|---|
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: Is eculizumab indicated?
Topics: Adult; Anemia, Aplastic; Anticoagulants; Brain Ischemia; Cerebral Hemorrhage; Fatal Outcome; Hemoglo | 2012 |
High incidence of venous thrombosis after surgery for abdominal aortic aneurysm.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aortic Aneurysm, Abdominal; Drug Administration Schedule; E | 2009 |